IACP News Roundup - March 16, 2018

To keep you informed on all of IACP  member-driven initiatives  and latest legislative & regulatory updates, IACP has debuted a weekly  News Roundup ! Check out this week's report below, and email us at  [email protected]   with questions.


ABOUT

IACP Job Postings

IACP is looking for someone to join our team! Are you energetic, creative and thrive in a fast-paced environment with great Communication skills?  Please see the IACP Communications Director position for more information.


Member-Driven Initiatives

So far IACP has been really busy this year.  We have already shared with you quite a few programs - and we aren't done yet!

We have done a look back at what we accomplished together in 2017 and shared our plan for 2018, along with my EVP message to membership.  We have highlighted our amazing Committee Chairs and their goals for the year that are driven by YOU, IACP's members.  We have a new energy and passion that is tangible and really shines through with every committee meeting, board meeting, member engagement and certainly, at the staff level.

The IACP COMP PAC Newsletter came out with a teaser on the upcoming COMP PAC Tiers.

The new Executive Membership is now available and opened with a fantastic response.  The day it was released we got our very own, IACP President-elect Jennifer Burch to sign up.  A couple days later, IACP Vice President and IACP COMP PAC Chair, Shawn Hodges, joined the fun.  Now, we can add IACP Board Member and Infrastructure Review Committee Chair, Jeffery Bray, as our THIRD Executive Member!

Corporate Member Tiers were announced on Monday this week!  We are excited to recognize and thank our Corporate Members for all their support.

Keep an eye on your inbox, because we are sneaking in a few more programs and some awesome games...the IACP Ambassador Program and some incredible CCH competitions you won't want to miss!

The webinar programs and structure will be out in a couple weeks.  Our Education Committee has been hard at work on this and has come up with some incredible CE programs for you!

 
EVP and IACP Ambassador Tracking

Stay tuned for the rollout of the NEW IACP Ambassador Program that the IACP Membership Committee, Chaired by Doug Yoch will unveiling soon!  The IACP Ambassador Program give IACP members an opportunity to represent IACP as an ambassador at specific conferences and events.  In return, IACP Ambassadors will receive discounts on registration to IACP events and other benefits.  This is one more way we are listening to your feedback and requests!  We heard that you want to be able to represent IACP more at other conferences and events by speaking and we are answering your call! More details coming soon!

  • Doug Yoch, IACP Board Member and IACP Membership Committee Chair recently spoke to pharmacy students at University of South Carolina (USC) during their Pharmacy Day.  Doug, an alumni of USC, had an opportunity to share more about IACP and why membership was important.  While he was there he got 15 new pharmacy student members signed.  Thank you, Doug!
  • Lauren Aller, IACP Member, will be speaking and helping IACP exhibit at the LP3 Network has asked IACP to speak and exhibit at their Student Compounding Competition held in Aventura, FL on March 17th - 18th.  This is another wonderful opportunity to work with students and share more about IACP and what incredible benefits IACP offer to students including a FREE student membership!  
  • IACP will be attending the PCCA ACT Legislative Conference in Washington D.C. on April 18th - 19th as well. The conference begins with a half day of educational programming on Wednesday afternoon followed by an opening dinner, a legislative breakfast on Thursday followed by Congressional visits and a closing reception.
Member Initiatives

IACP Initiatives - Storm the Hill at CCH!

IACP Executive Vice President Cynthia Blankenship, Esq.
Your Presence is Needed at CCH!

As a former Congressional staffer in the U.S. Senate and U.S. House of Representatives, I am often asked why storming the Hill during 
Compounders on Capitol Hill (CCH) is so important and whether it's worth your time away from patients and your pharmacy. My answer is a resounding YES and here's why.

I've been on the other side of the table from you with the Senator and Congressman for many years during fly-ins on the Hill. Every other day, we met with lobbyists and attorneys and not to say that isn't important - but  no one can represent YOUR voice and the voices of your patients like YOU. If you aren't showing up, you are gambling that someone else will represent your voice, your passion for preserving your industry and patient access, and share your personal stories - and that's a dangerous gamble to make. We have an incredible government affairs team at IACP that we are grateful for, but as they would also admit as former Congressional staffers - no voice is as powerful as YOUR voice. Compounding is personal and so are your stories and the stories of your patients.

Your Voice Matters - Your Vote Matters: The most common misconception I saw as a Congressional staffer was that pharmacists didn't understand how powerful their voice was and what makes them different from their opposition.  YOU have something that no one else has - YOUR vote which spans in every Congressional district. You are a constituent; your patients are constituents and the providers you work with are constituents - and, constituents vote during elections, they tell those they work with, their families, and their friends how to vote as well. In times like these when our opposition is actively working against us on a daily basis - it's important to keep in mind that none of our opposition has this benefit that you have - but you have to make that benefit count. It's what makes you different and it's what makes YOUR presence as we Storm the Hill and walk the Halls of Congress at CCH so important.
 
If you are new to Hill day or feel that you want to ensure someone that is a Hill veteran goes to the Hill with you, don't let this hold you back! We have added an option on the registration form where you can let us know! We have a vast army of volunteers from former Congressional staff, Corporate Members, and other Hill day veterans lined up ready to storm the hill with you!

We are also going to shake it up this year with some incredible competitions coming your way for those who get the most folks to CCH! We have some amazing prizes and awards in store! Stay tuned next week for the launch of these competitions and more information! No one's voice is more powerful than your voice on Capitol Hill and in getting your colleagues to join us at CCH!

Also, please note that in order to ensure you are able to attend all your scheduled meetings, please do not schedule your flight before 6 p.m. on Tuesday, June 26th!

So, tell your colleagues and tell your friends to j oin us in Washington, D.C. for the 24th Annual  Compounders on Capitol Hill  (CCH), June 23-26, 2018 at the Renaissance Washington D.C. Downtown Hotel.

The stakes are too high and this is not the time to sit on the sidelines and hope that someone else will represent your voice. Join your colleagues in preserving patient access and join us in the Halls of Congress to deliver this messaging like ONLY YOU can.



Please email  [email protected] if you have any questions,  OR if you'd like to get more involved with IACP!  We'd love your help in achieving these 2018 goals!


IACP loves our Committee Chairs and Members!  We couldn't do it without you.  If you are interested in joining a committee, let us know!  Please email Jennifer Petska at [email protected] for more information.

Registration for Compounders on Capitol Hill is 
NOW OPEN!

Compounders on Capitol Hill  (CCH) brings together the top-level compounding pharmacists and technicians from across the country with the same goal - to protect pharmacy compounding.  Network and  Reconnect  with old friends and meet new colleagues who share your passion and interest in protecting, promoting and advancing pharmacy compounding!

The 24th Annual Compounders on Capitol Hill will be held June 23-26, 2018 at the Renaissance Washington DC Downtown Hotel. With more than 400 expected attendees in 2018.



___________________________________________________________________________
NEWSROOM


IACP Responds to New Pew Report on State Oversight of Compounding


On Monday, February 26, 2018, The Pew Charitable Trusts has released a Report entitled, State Oversight of Drug Compounding: Major Progress Since 2015 but Opportunities Remain to Better Protect Patients. The report claims to provide an overview of the current landscape of sterile compounding oversight by analyzing quality standards, state challenges, office-use, sterile compounding, and in-state pharmacy inspections. However, the report is comprised of a multitude of inaccurate information and data with very little input from State Boards of Pharmacy.  The full Pew report can be read  here  and the press release can be accessed  here . To read the full IACP statement, please click here.


Associate Attorney General Brand Announces End To Use of Civil Enforcement Authority to Enforce Agency Guidance Documents


On Thursday, January 25th, the  Associate Attorney General  issued a memorandum that prohibits the Department of Justice from using civil enforcement authority to "convert agency guidance documents into binding rules."  According to the Memorandum published on the Department of Justice website, Justice Department civil litigators are prohibited from using guidance documents - or noncompliance with guidance documents - to establish violations of law in affirmative civil enforcement actions. Further, in that same news release, DOJ Associate Attorney General Brand stated "Although guidance documents can be helpful in educating the public about already existing law, they do not have the binding force or effect of law and should not be used as a substitute for rulemaking." 

PLEASE NOTE: IACP currently is reviewing this information and determining what impact this has for current FDA Guidance for Industry (GFI) documents. IACP will send you additional updates as they become available.

Please click here to view the Department of Justice's press release.


Other DOJ News


As one of her final acts before leaving DOJ, Associate Attorney General Rachel Brand  announced that DOJ would no longer permit its lawyers to use guidance documents issued by its "client" agencies as a basis for civil enforcement. The "Brand Memo" provides guidance about DOJ's use of guidance, as we described  here.
 
In a couple of coordinated speeches, DOJ officials reiterated and clarified this position. Deputy Associate Attorney General Stephen Cox, who worked closely with Rachel Brand, spoke at the Federal Bar Association Qui Tam Conference on February 28, 2018. Cox described federal agencies' use of guidance in lieu of formal regulatory rulemaking required under the Administrative Procedure Act: "Rulemaking can be cumbersome and slow, of course, and sometimes agencies have used guidance as a short-cut to effectively make new rules when they should have undertaken notice-and-comment rulemaking instead." He referenced a recommendation from the Administrative Conference of the United States (ACUS) to make clear that "the public may take a lawful approach different from the one set forth in" a guidance document. Per Cox, the Brand memo implements the ACUS recommendation: "The Brand Memo makes clear that we won't be using noncompliance with a guidance document to prove a violation of the applicable statute or regulation. In other words, we won't use our affirmative civil enforcement authority to effectively convert a nonbinding guidance document into a requirement that has the force or effect of law." 

Click here to read the full blog post. 


IACP Member Alerts
  • IACP Submits Comments to Kansas - March 5, 2018
  • Executive Member Reveal - March 5, 2018
    •
     
  • IACP's Comp PAC Newsletter - February 28, 2018
  • IACP Committee Chairs - Part Five - February 27, 2018
  • CCH Newsletter - February 27, 2018
  • IACP Responds to New Pew Report on State Oversight of Compounding - February 26, 2018
  • IACP Committee Chairs - Part Four - February 26, 2018
  • IACP Committee Chairs - Part Three  - February 22, 2018
  • IACP Committee Chairs - Part Two - February 21, 2018
  • - February 20, 2018

    •
    INDUSTRY NEWS


    • Researchers at Oregon State University have made a key advance in the fight against drug resistance, crafting a compound that genetically neutralizes a widespread bacterial pathogen's ability to thwart antibiotics.
    • The findings are important because antibiotic resistance is a growing global threat, with the percentage of isolates with multidrug resistance on the rise for many bacteria.
    Cigna Agrees to Buy Express Scripts for More Than $50 Billion    
     
    California investigates Aetna re decisions to deny care
     
    NCPA campaign to collect stories of PBM abuses:


    Inside Health Policy  - Pew, NABP Report: State Alignment With Compounding Best Practices Improving
     
    February 26, 2018
     
    The Pew Charitable Trusts and the National Association of Boards of Pharmacy in a report released Monday (Feb. 26) praise states for implementing what they believe are best practices in overseeing compounding, but they say more can be done to increase inspection frequency and develop a risk-based inspection framework. Since Pew's last survey in 2015, more states have adopted United States Pharmacopeia standards for compounding and many have worked to harmonize their state regulations with federal law, but inspection frequency has gone down.  To read more click  here .


    Bloomberg - States, FDA Limit Access to Compounded Drugs, House Republican Says
    By Bronwyn Mixter February 26, 2018 5:43PM ET
    • Report says 39 states and D.C. don't permit traditional pharmacies to compound drugs for office use
    • Republican lawmaker is concerned that patients won't have access to the medications they need
    (Bloomberg Law) -- Traditional compounding pharmacies should be allowed to compound medications without prescriptions for use in doctor's offices, Rep. Buddy Carter (R-Ga.) told Bloomberg Law Feb. 26.  Thirty-nine states and the District of Columbia currently don't permit such office-use compounding and 11 states allow it, according a report released Feb. 26 by the Pew Charitable Trusts and the National Association of Boards of Pharmacy (NABP). This contrasts to 2015, when Pew said two-thirds of states allowed office-use compounding to some extent. Office-use compounding is when a pharmacist makes a drug without receiving a prescription and transfers it to a requesting physician to keep on hand for when it's needed by a patient. To read more click here.


    ___________________________________________________________________________
    IACP Affiliate News

    USP Announces Comment Period for 
    Chapters <795> and <797>

    USP General Chapters <795>   Pharmaceutical Compounding - Nonsterile Preparations , and <797>   Pharmaceutical Compounding - Sterile Preparations   are in the active revision process. The purpose of this alert is to provide you details of upcoming opportunities where you can participate in the public comment process for the proposed revisions.   
     
    To provide a unified approach to quality compounding, USP intends to align the timing and content of General Chapters <795>, <797>, and <800>Hazardous Drugs-Handling in Healthcare Settings.   Among other proposed content in the revisions, hazardous drug handling sections in <795> and <797> will reference General Chapter <800>.
     
    General Chapter <800> was completed and published in February 2016, and the content of that chapter is not currently under revision.
     
    Below are the timeline and associated web links for you to engage and provide input during the public comment periods for <795> and <797>.  You will be able to provide written comments through the USP website from March 30, 2018 to July 31, 2018 for USP <795>, and from July 28, 2018 to November 30, 2018 for USP <797>.




         Schedule & Links for Compounding Standards
     
    Click the links for access where the respective information will be posted 
     
     
     
    <795> *
    Pharmaceutical Compounding -  Nonsterile Preparations
    <797> *
    Pharmaceutical Compounding -  Sterile Preparations
    Pre-Posted on the USP Website for Public Comment**
    Published in thePharmacopeial Forum
    Open Microphone Session
     
    Registration will open 
     
     
    March 15, 2018
     
     
    August 5, 2018
    Public Comment Period will close
     
    Intended Publication DateUSP - NF
     
    Anticipated Official Date
    December 1, 2019
    December 1, 2019
     
    *   The current published versions of USP-NF General Chapters <795> and <797> are official until new chapters 
    become official.

    ** This pre-posting allows extra time, beyond the typical 90 day period, for stakeholders to review and provide 
    input.



    USP Offers IACP Members Special Discount for Spring Session of Safe Compounding & Safe Handling of Hazardous Drugs Week Course!


    IACP is diligently working to  expand our affiliate relationships pursuant to the feedback we received from IACP membership survey responses to offer our member more discounts and benefits.  We are currently working on two additional opportunities with USP and will share more about them soon!  

    Also, please let us know if there are other specific organizations that you would like to see discounts and benefits from. Email us at [email protected] with that info today!

    So far 5 IACP members have registered for this amazing opportunity!  You are missing out if you don't take advantage of these discounts.  Don't be left in the dark about these important topics! 


    IACP Members: 
    USP is offering you special Early Bird Discount rates for its Live Courses <800>, <797>, <795> - Spring Session to be held March 21-23, 2018: 
    Safe Compounding & Safe Handling of Hazardous Drugs Week

    Please click here  to access more information including Special Codes created just for IACP Members.

    Thank you IACP Affiliate, USP, for offering these special member discounts!



    USP Debuts New Resource - USP <800> HazRx™ Mobile App. 
    The <800> HazRx™ Mobile App is an innovative tool that combines information from three trusted data resources (NIOSH, RxNorm, General Chapter <800>) to help identify hazardous drugs at the point of practice and to inform the healthcare worker on what measures to take to help reduce their risk in accordance with established standards.

    As we all move toward safer handling of hazardous drugs in the work place, USP encourages early adoption and implementation of USP General Chapter <800> to protect the public health in all healthcare settings.

    Read more here!
       

    ___________________________________________________________________________
    IACP Corporate Member News


    Letco Medical, L.L.C. Announces Launch Of Innovative Education Value Program For Compounding Professionals To Enhance Pharmacy Profitability

    WAYNE, Pa. ,  March 1, 2018  /PRNewswire/ -- Letco Medical, L.L.C. ("Letco Med"), a leading national supplier of quality compounding products, supplies and equipment, together with the American College of Apothecaries ("ACA"), a leader in providing continuing education for compounding pharmacists and technicians, announce the launch of the Education Value Program ("EVP").  This program provides compounding professionals access to best-in-class continuing education for up to 60% less than equivalent market offerings. 

    Read the press release here.
       

    ___________________________________________________________________________
    ADVOCACY
    State Advocacy
    • IACP Submits Comments to Kansas State Board of Pharmacy on Proposed Regulations K.A.R. 68-13-2, 68-13-3, and 68-13-4.
    The  International Academy of Compounding Pharmacists (IACP)  has submitted formal comments to the  Kansas State Board of Pharmacy  on  Proposed Regulations K.A.R. 68-13-2, 68-13-3, and 68-13-4.   The March 5, 2018 submission reflects IACP's continuing effort to respond to each and every state action impacting pharmacy compounding. IACP will continue these efforts and will work closely with State Pharmacist Associations and State Boards of Pharmacy to support all state action preserving patient access to compounded medications. The  IACP Legislative Committee  chaired by  IACP Board Member Anthony Grzib, RPh  is continuing to look for additional ways IACP can engage in preserving patient access to compounded medications.
     
    Please click here to read IACP's letter to the Kansas State Board of Pharmacy. 
    Please click here to read IACP's full comments.
    Please click here to read the Proposed Kansas Regulations K.A.R. 68-13-2, 68-13-3, and 68-13-4. Compounding.
     
    IACP Comments Excerpt: 
    The International Academy of Compounding Pharmacists (IACP) represents more than 4,000 pharmacists, technicians, students, and members of the compounding community who focus on the specialty practice of pharmacy compounding. Compounding pharmacists work directly with prescribers including physicians, nurse practitioners and veterinarians to create customized medication solutions for patients and animals whose health care needs cannot be met by manufactured medications. IACP works diligently to preserve patient access to these vital compounded medications.
     
    IACP would like to thank the Kansas Board of Pharmacy for this opportunity to present thoughts on the proposed K.A.R. 68-13-2, 68-13-3, and 68-13-4 (Proposed Regulations). IACP supports the Kansas Board of Pharmacy's mission to ensure that patients throughout the State of Kansas receive safe, effective and quality compounded medications. IACP understands and supports the need to protect public health. When developing and implementing regulations, it is essential to preserve patient access to vital compounded medications, the prescriber-patient pharmacist triad, and the right of a patient to choose their pharmacist. Prescribers must have the right to prescribe medications that best fit the needs of their patients.
     
    IACP has reviewed the Proposed Regulations and would like to provide the following stakeholder input. IACP has heard from pharmacists as well as prescribers who will be impacted by the Proposed Regulations when compiling this input.
     
    First, IACP commends the Board for recognizing the need for pharmacists to provide both sterile and nonsterile compounds to prescribers for office-use. Pharmacists' ability to provide compounded medication for prescribers to use within their practice setting is critical to patient care.  
     
    Second, while IACP supports the Board's intent to create compounding standards consistent with U.S. Pharmacopeia (USP) requirements, IACP is concerned that certain portions of the Proposed Regulations are inconsistent with current standards found within USP General Chapters <795> and <797>, such as:
    • Defining terms or compounding categories within K.A.R. 68-13-2 that either do not exist within <795> and <797> or conflict with the current USP definitions.
    • Imposing restrictions on the use of compounding ingredients within K.A.R. 68-13-3 which currently do not exist with <795> and <797>.
    • Creating beyond use dating requirements within K.A.R. 68-13-3 and 68-13-4 that are unclear and potentially more restrictive than those found in <795> and <797>.
    • Establishing sterile compounding risk categories within K.A.R. 68-13-4 that conflict with each other and are inconsistent with those established within <797>.
    In order to best preserve patient access to vital compounded medications, IACP urges the Board to make revisions to specific sections of the Proposed Regulations (see attached), along with the remainder of K.A.R. 68-13-2, 68-13-3, and 68-13-4 to align the Proposed Regulations with the current standards found within USP <795> and <797>.

             IACP appreciates the opportunity to present its perspective to the Kansas Board of Pharmacy and is available to answer any questions the Board may have. IACP looks forward to any opportunity to work with the Board regarding this or any other matter to achieve the mutual goal of protecting and promoting the health and safety of Kansans through continued access to high quality compounded medication. Read the entire letter
    here.
     
    • IACP Submits IL Comments!  IACP submitted formal comments to the Illinois Department of Financial and Professional Regulation on Proposed Amendments to Regulations Implementing Illinois Pharmacy Practice Act. 
    IACP Comments Excerpt:   
    IACP would like to thank the Illinois Department of Financial and Professional Regulation 
    ("IDFPR") for this opportunity to present thoughts on the proposed amendments to Section 1130.640 of the Illinois regulations implementing the Pharmacy Practice Act (the "Proposed Rules"). IACP supports the IDFRP's mission to ensure that patients throughout the State of Illinois receive safe, effective and quality compounded medications. IACP understands and supports the need to protect public health. When developing and implementing regulations, it is essential to preserve patient access to vital compounded medications, the prescriber-patient-pharmacist triad, and the right of a patient to choose their pharmacist. Prescribers must have the right to prescribe medications that best fit the needs of their patients. 

    IACP has reviewed the Proposed Rules and would like to recognize the IDFPR for incorporating much of the stakeholder input submitted during prior comment and review periods. IACP has heard from pharmacists as well as prescribers who will be impacted by the Proposed Rules that specific provisions still exist within the Proposed Rules that need further clarification or will cause unnecessary constraints in patients being able to access needed compounded preparations. 
     
    First, IACP had the opportunity to review the recommendations being submitted by the Illinois Pharmacists Association ("IPhA") and would like to express support for the IPhA's proposed modifications to Sections 1130.640(c),(d),(e), and (f) of the Illinois regulations. IPhA's proposed changes are necessary to ensure that these portions of Section 1130.640 incorporate consistent practice requirements that align with United States Pharmacopeia ("USP") General Chapters 795 and 797 standards currently governing compounding pharmacies. The IPhA's recommendations in these areas will safe-guard patient safety and place the Proposed Rules in line with best practices while also preserving patient access to compounded medications. Read the entire letter here. 

    • IACP provides our members with a weekly state tracking report - including legislative and regulatory updates! Check out  this week's Compounders Stateside report here - you will need to log-in to view this members-only report. 
    • House and Senate pass legislation to rein in pharmacy benefit managers 
      By  Benjamin Hardy,  Arkansas Nonprofit News Network
    On Wednesday, both chambers of the Arkansas legislature approved identical versions of a bill to regulate pharmacy benefit managers, the powerful healthcare companies at the center of a dispute over cuts in reimbursements paid to pharmacists. Governor Hutchinson has committed to signing the legislation, which sponsors say is likely the first of its kind in the nation.

    Senate Bill 2 passed in a floor vote of 30-2, with all members voting; the 35-seat Senate currently has three vacancies. House Bill 1010 passed its chamber, which has one vacancy, by a vote of 92-2, with two members voting "present" and three not voting.

    The General Assembly is meeting for a three-day special session that was called by Hutchinson on Monday to address the PBM issue and a grab bag of other bills. The session was expected to wrap up on Thursday. To read more click here.
    • Arkansas pharmacists call out PBM abuses: In anews conference this past week, the Arkansas Pharmacists Association shed light on several egregious PBM abuses, including reimbursement cuts in the Arkansas Works program and price differences between what PBMs pay their own pharmacies and what they pay independent pharmacies for the same claim. As APA's Scott Pace said: "Pharmacists take care of people, folks, and that's what they're trying to do ... The situation is unsustainable and it requires a fix." Please take a moment to listen to this conference and share with your colleagues.
    • AVAILABLE FROM IACP! State-by-State Analysis of Office-Use Compounding Regulations! Your Government Affairs team just released a State-by-State Analysis of Office-Use Regulations! We researched State regulations, State notices, State activity, and called State Boards of Pharmacy when regulations conflicted with actions to determine each State's office-use actions. In the instance where a State had recently changed its office-use practices, we called to determine why, and the response was noted when FDA had communicated that State law was pre-empted with Federal law.
    You will find two documents - (1) the State-by-State analysis and (2) a complete supplemental document where all State regulations and actions are housed. The State-by-State analysis is a quick reference guide that demonstrates State regulations and current thinking on office-use and all supporting documents to this research can be found in the supplemental document. The DQSA Coalition intends to use this document to see whether model office-use State laws exist, to educate and assist States that are attempting to change office-use practices on the intent of Congress, and to focus on specific states for the State Board of Pharmacy/Board of Medicine Coalition Letter that is coming soon!    
    • USP General Chapter <800> State Adoption Status Chart. NASPA has developed a chart providing each state's current adoption status of USP's General Chapter <800>. Thank you, IACP Affiliate NASPA, for developing this invaluable tool!

    ___________________________________________________________________________
    Grassroots


    • Grassroots Advocacy - Tell Your Patients and Providers to sign up for the Partnership for Personalized Prescriptions P3 Patient Advocacy Website! Patient Advocacy efforts make a real difference. That's why we need our IACP members' help to encourage more people to Join P3 and to Share their Stories! So many of our own IACP members have joined the P3 effort. Share this resource with everyone in your communities - your patients, your providers, your staff, your friends and family.
    • Your Patients and Providers are Asking their Representatives to Support HR 2871 with 535 messages sent to the Hill! Encourage your patients and providers to visit P3's Patient Advocacy Website. Advocates can instantly send a direct message to their Congressional Representatives, asking them to cosponsor the bipartisan legislation, HR 2871. Visit P3's Patient Advocacy Website. It's easy to use and will only take a few minutes to send an important HR 2871 message to Congress.
    • IACP MEMBERS: We NEED your patient stories! If you missed the Congressional Hearing on the implementation of the DQSA, these stories were highlighted as to why patient access to compounded medications needs to be preserved. These stories are vital to share with Congress and essential in our mission of preserving patient access. It's easy to tell patients how to share their stories! You can send them here to Share their Stories and the rest is taken care of to ensure their voice is heard by Congress! How have compounded medications helped your community? Please email IACP Communications at [email protected].
    ___________________________________________________________________________
    IACP COMP PAC


    Calling all IACP members in Utah or the surrounding States, stay tuned for exciting news on how YOU can attend a gathering with Congressman Chris Stewart!  He's coming to your area soon, and IACP's very own Board Member, Jeffery Bray, is hosting the event!  Congressman Stewart serves on the powerful House Appropriations Committee.  Congressman Stewart is a longtime champion for compounding pharmacy and he has fought to preserve patient access to vital compounded medications.  Congressman Stewart has sponsored H.R. 2871, the Preserving Patient Access to Compounded Medications Act.  This is an event you do not want to miss!  

    Keep an eye on your inbox for the next IACP COMP PAC email coming next week with additional details.


    IACP COMP PAC offers the rare and incredible opportunity to meet with Members of Congress one-on-one to share your and your patients' stories. We have heard your request for more opportunities to meet Members of Congress in this rare, small setting, and your COMP PAC is answering the call by having more PAC events than ever at #CCH2018!
     
    As a sneak peek on the events to come, IACP COMP PAC is continuing the tradition of offering the amazing opportunity to break bread with a Member of Congress over a glorious three course meal at Ruth's Chris Steak House, Monday, June 25, 2018, 7:00 p.m. - 9:00 p.m. You will have the incredible opportunity to speak to the Member of Congress in a fun and relaxed environment. This event also serves as the SOLE IACP PAC Fundraiser of the YEAR!
     
    Your attendance and donations to COMP PAC events are essential in helping preserve patient access to compounded medications. Your voice makes a tremendous difference - we need YOU at IACP COMP PAC events this year!

    To buy your IACP CCH COMP PAC Dinner and Fundraiser Tickets, click here or contact Ashlyn at [email protected].


    ___________________________________________________________________________
    IACP Foundation


    14th Annual Rx Mixer: Aloha State of Mind

    The ONLY IACP Foundation fundraiser of the year and helps support the Foundation's invaluable mission! This fun Party with a Purpose is being held Sunday, June 24, 2018 from 6:30 p.m. - 11:00 p.m. Early Bird Price is $150 per person until March 31, 2018 (one event ticket and three drink tickets).  The Regular Price is $175 and Late Registration is $200 after June 10, 2018. This is a separate ticketed event.
     
    This event ensures a night to remember and an awesome opportunity to relax and party all night with your colleagues. Join us in paradise and come relax with your colleagues and friends.  Guests will be treated to a fun evening of classic food, cold drinks, fellowship, and Dueling Pianos to lead us in song and cheer!  Try your hand at the Live Auction, Silent Auction by the IACP Foundation, Memorabilia Silent Auction by GrandStand Sports and the Reverse Card Draw!
     
    Join us in paradise and
    Party with a Purpose by registering  here.


    To donate, sponsor, or volunteer please contact Jennifer at [email protected].